Correlation of Blood Gene Expression (TruGraf Liver) With Liver Biopsy in Pediatric Liver Transplant Recipients
Conditions: Liver Transplant; Complications; Liver Failure, Acute Interventions: Diagnostic Test: TruGraf ® Liver gene expression panel (GEP) Sponsors: Children ' s Mercy Hospital Kansas City; Eurofins Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 16, 2024 Category: Research Source Type: clinical trials
EQUITY GI: A Prospective Study to Enhance Quality, Inclusivity, and Trial Participation in Black Patients With Gastrointestinal Cancer.
Conditions: Gastrointestinal Cancer; Colon Cancer; Rectal Cancer; Anal Cancer; Esophageal Cancer; Stomach Cancer; Appendix Cancer; Pancreas Cancer; Liver Cancer; Neuroendocrine Tumors Interventions: Other: EQUITY GI Sponsors: Case Comprehensive Cancer Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 16, 2024 Category: Research Source Type: clinical trials
Contrast Enhanced Ultrasound to Evaluate Response to Chemoembolization in Patients With Liver Tumors
Conditions: Liver Neoplasms Interventions: Drug: Sulfur Hexafluoride Lipid Microspheres; Procedure: Contrast-Enhanced Ultrasound; Procedure: Transarterial Chemoembolization; Other: Medical Chart Review Sponsors: Thomas Jefferson University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 15, 2024 Category: Research Source Type: clinical trials
Evaluation of Liver Damage in Patients With Anorexia Nervosa by Blood Biomarker Analysis
Conditions: Anorexia Nervosa Interventions: Other: Patients with Anorexia Nervosa Sponsors: Nantes University Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 15, 2024 Category: Research Source Type: clinical trials
Radiotherapy Delays Second-line Drug Therapy for Oligo Progressive Primary Liver Cancer
Conditions: Hepatocellular Carcinoma; Radiotherapy Interventions: Radiation: radiotherapy Sponsors: Shandong Cancer Hospital and Institute Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 15, 2024 Category: Research Source Type: clinical trials
SAMe in Prevention of Oxaliplatin-associated Liver Injury
Conditions: Colorectal Cancer; Liver Metastases; Liver Metastasis Colon Cancer; Liver Injury; Sinusoidal Obstruction Syndrome; 5-Fluorouracil Toxicity; Liver Toxicity, Chemically-Induced Interventions: Radiation: Standard of care oxaliplatin-based chemotherapy; Dietary Supplement: S-adenosylmethionine (SAMe) supplement; Procedure: Surgery Sponsors: Cedars-Sinai Medical Center; Jarrow Formulas Inc Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 14, 2024 Category: Research Source Type: clinical trials
Perioperative Hemostasis Management in Liver Transplantation
Conditions: Liver Transplant; Complications Sponsors: Soci été Française d ' Anesth ésie et de Réanimation; Laboratoire français de Fractionnement et de Biotechnologies Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 14, 2024 Category: Research Source Type: clinical trials
Different Exercise Modalities in the Treatment of NAFLD and Their Impact on Myokines
Conditions: NAFLD; Nonalcoholic Fatty Liver Disease; Fatty Liver, Nonalcoholic; Fatty Liver Interventions: Other: Exercise; Behavioral: Motivational Interviewing Sponsors: Yeditepe University; TUB İTAK Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 14, 2024 Category: Research Source Type: clinical trials
The AMARA (As Much As Reasonable Acceptable) Study
Conditions: Liver Cancer Interventions: Device: Transarterial Radioembolization Sponsors: University Hospital of Patras Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 13, 2024 Category: Research Source Type: clinical trials
Endothelin Receptor Antagonism With Ambrisentan to Treat Hepatorenal Syndrome
Conditions: Hepatorenal Syndrome; Liver Cirrhosis; Acute Kidney Injury; Ascites Hepatic Interventions: Drug: Ambrisentan; Drug: Terlipressin Sponsors: Noorik Biopharmaceuticals AG Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 13, 2024 Category: Research Source Type: clinical trials
Efficacy of Canagliflozin Versus Metformin in Women With Polycystic Ovary Syndrome
Conditions: Polycystic Ovary Syndrome; Non-Alcoholic Fatty Liver Disease Interventions: Drug: Canagliflozin 100mg Tab; Drug: Metformin Hydrochloride Sponsors: Ping Li,MD Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 13, 2024 Category: Research Source Type: clinical trials
A Clinical Study of Curcuvail ® in Patients With Non-alcoholic Fatty Liver Disease
Conditions: Fatty Liver Without Mention of Alcohol Interventions: Drug: Test Product: Curcuvail ® 250mg capsule (Curcuma longa Extractcontaining 35% Curcuminoids); Drug: Placebo product Sponsors: COD Research Private Ltd Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 13, 2024 Category: Research Source Type: clinical trials
Safety of Atezolizumab-Bevacizumab in Liver Transplanted Patients With Advanced Hepatocellular Carcinoma
Conditions: Liver Transplant; Hepatocellular Carcinoma Recurrent; Systemic Treatment Interventions: Drug: Systemic therapy Sponsors: Assistance Publique - H ôpitaux de Paris Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 12, 2024 Category: Research Source Type: clinical trials
Observational Study Protocol: LIVER-R
Conditions: Hepatobiliary Cancers Interventions: Other: Durvalumab-based combination therapies in observational study setting; Other: Durvalumab-based combination therapies in observational study setting Sponsors: AstraZeneca; ICON plc Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 12, 2024 Category: Research Source Type: clinical trials
Generation of Organotypic Liver Cultures for the Identification of Biomarkers for the Prevention and Treatment of Liver Fibrosis
Conditions: Hepatic Fibrosis Interventions: Diagnostic Test: Biopsy from patients undergoing surgery abdominal. Sponsors: Regina Elena Cancer Institute; Federico II University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 9, 2024 Category: Research Source Type: clinical trials
